Secondary CV Prevention in South America in a Community Setting: The PURE Study
ConclusionsThere are large gaps in the use of proven medications for secondary prevention of cardiovascular disease in South America. Strategies to improve the sustained use of these medications will likely reduce cardiovascular disease burden substantially. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013
ConclusionsLifestyle habits have deteriorated over time with increases in obesity, central obesity, and diabetes and stagnating rates of persistent smoking. Although blood pressure and lipid management improved, they are still not optimally controlled and the use of evidence-based medications appears to have stalled apart from the increased use of high-intensity statins. These results underline the importance of offering coronary patients access to modern preventive cardiology programs. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Availability, Use, and Barriers to Cardiac Rehabilitation in LMIC
ConclusionsOur results illustrate that the published reports reflects heterogeneity of CR availability and use in LMIC. Overall, CR is insufficiently available and underutilized. Further characterization of CR in LMIC, especially in Asia and Africa, is necessary to develop targeted strategies to improve availability and utilization. Patient, physician, and systems factors must be addressed to overcome barriers to participation in CR in LMIC. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Relatives' Presence During Cardiopulmonary Resuscitation
ConclusionsAvoiding relatives' presence while performing cardiopulmonary resuscitation is the most frequent choice made by the surveyed physicians who treat critical Argentine patients. The main causes for discouraging family presence during cardiopulmonary resuscitation or other critical procedures include the following: risk of misinterpretation of the physician's actions and/or words; risk of a relative's decompensation; uncertainty about possible reactions; and interpretation of the relative's presence as negative. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research
Publication date: December 2017Source: Global Heart, Volume 12, Issue 4Author(s): Michael M. Engelgau, Emmanuel Peprah, Uchechukwu K.A. Sampson, Helena Mishoe, Ivor J. Benjamin, Pamela S. Douglas, Judith S. Hochman, Paul M. Ridker, Neal Brandes, William Checkley, Sameh El-Saharty, Majid Ezzati, Anselm Hennis, Lixin Jiang, Harlan M. Krumholz, Gabrielle Lamourelle, Julie Makani, K.M. Venkat Narayan, Kwaku Ohene-Frempong, Sharon E. StrausAlmost three-quarters (74%) of all the noncommunicable disease burden is found within low- and middle-income countries. In September 2014, the National Heart, Lung, and Blood Institute held a...
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
The Burden of Heart, Lung, and Blood Diseases in the United States, 1990 to 2016: Perspectives from the National Heart, Lung, and Blood Institute
Publication date: December 2017Source: Global Heart, Volume 12, Issue 4Author(s): Eric Coles, George A. Mensah (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Table of Contents
Publication date: December 2017Source: Global Heart, Volume 12, Issue 4Author(s): (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Leptin, An Adipokine With Central Importance in the Global Obesity Problem
Publication date: Available online 13 December 2017Source: Global HeartAuthor(s): Jeffrey I. Mechanick, Shan Zhao, W. Timothy GarveyAbstractLeptin has central importance in the global obesity and cardiovascular disease problem. Leptin is principally secreted by adipocytes and acts in the hypothalamus to suppress appetite and food intake, increase energy expenditure, and regulate body weight. Based on clinical translation of specific and networked actions, leptin affects the cardiovascular system and may be a marker and driver of cardiometabolic risk factors with interventions that are actionable by cardiologists. Leptin su...
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Cardiovascular Risk Factors in Rural-to-Urban Migrants Versus the Urban-Born: Evidence From Chennai, India
Publication date: Available online 13 December 2017Source: Global HeartAuthor(s): Nikkil Sudharsanan, Lulu Tian, Emily Ambinder, Alex Ambinder, Neil K. Mehta, Rajendra Pradeepa, Mohan Deepa, Viswanathan Mohan, Mohammed K. Ali (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular Disease
ConclusionsThe robust curriculum development, testing, and implementation process described affirm that NPHW in diverse settings can be trained in implementing measures for CVD prevention and control. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the Fourth Round of the SuRFNCD-2011
ConclusionsWe report concerning prevalence of self-reported CHD and chronic stable angina pectoris in the adult population of Iran. The constellation of raised systolic and diastolic blood pressures was significantly predictive of the presence of self-reported CHD. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Large-Scale Epidemiologic Studies of Cardiovascular Diseases in China: Need for Improved Data Collection, Methods, Transparency, and Documentation
This study sought to review, describe, and evaluate all large-scale cardiovascular disease (CVD) studies completed in China. We undertook a review of all large-scale CVD studies completed in China to describe and evaluate their design, implementation, and dissemination in published medical reports. Seventeen studies met the inclusion criteria. There were substantial variations in study design, geographic location, and data collection. Most studies lacked standard study names, did not publish their methods, and provided no publicly available data. Few studies included underdeveloped regions or minority groups. Most publishe...
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Survival After MI in a Community Cohort Study: Contribution of Comorbidities in NSTEMI
ConclusionsNSTEMI confers a significantly higher mortality hazard beyond what can be attributed to comorbid conditions. More consistent and effective strategies are needed to reduce mortality in NSTEMI amid comorbid conditions. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Educational Inequalities in Cardiovascular Risk Factor and Blood Pressure Control in the Elderly: Comparison of MESA Cohort and Chilean NHS Survey Outcome Measures
ConclusionsThe study findings confirm that patterns and trends in prevalence, and absolute and relative inequalities vary by country, suggesting that context and cultural issues matters. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
Exploring the Barriers to and Facilitators of Using Evidence-Based Drugs in the Secondary Prevention of Cardiovascular Diseases: Findings From a Multistakeholder, Qualitative Analysis
ConclusionsOur findings reveal context-specific, health system factors that affect the patient's choice or ability to initiate and/or continue cardiovascular medication. Strategies to optimize cardiovascular drug use should be targeted and relevant to the health care system. (Source: Global Heart)
Source: Global Heart - July 5, 2018 Category: Cardiology Source Type: research
